Sida cordifolia L.: Ethnobotany, Phytochemistry, Phytonanotechnology, and Commercial Application

CONCLUSION: Several in-vitro and in-vivo studies validated the usage of S. cordifolia as antiinflammatory, antibacterial, antifungal, antiprotozoal, anthelmintic, anticancer, antiulcer, cardioprotective, hypoglycemic, etc. agent. Few patents are also related to S. cordifolia, and more research work needs to be carried out for its potential granted to use as an antiviral agent and other new drug discovery molecules.PMID:37861013 | DOI:10.2174/0113892010262937230919100024

Source: Current Pharmaceutical Biotechnology - October 20, 2023 Category: Biotechnology Authors: Sachin Kumar Sandeep Kumar Vineet Kumar Vishnoi Pradeep Kumar Dinesh Kumar Maheshwari Source Type: research